Press Releases and Statements

CHPA President and CEO, Scott Melville, today released the following statement in response to the U.S. Food and Drug Administration’s announcement of a joint meeting between its Advisory Committees on Nonprescription Drugs and Obstetrics and Reproductive and Urologic Drugs.

WASHINGTON, DC) – The Consumer Healthcare Products Association (CHPA) Educational Foundation today released the following statement announcing the 2022 U.S. Self-Care Marketing Awards finalists.

CHPA today released the following statement in response to a recent article from Kaiser Health News:

The Consumer Healthcare Products Association (CHPA) released a statement today upon the U.S. Food and Drug Administration (FDA) final rule establishing a regulatory category for over-the-counter (OTC) hearing aids.

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released a statement in response to the National Academies of Sciences, Engineering, and Medicine’s report titled Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health.

Consumer Healthcare Products Association (CHPA) Senior Vice President of Operations and Administration & Chief Financial Officer, Brian Green, CPA, CAE, has been named the 2022 Association CFO of the Year by Association TRENDS, one of the most prestigious honors in the association community.

Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released a statement today in response to a recent report published in the Journal of the American Medical Association (JAMA).

CHPA’s President and CEO, Scott Melville, today released a statement in response to news of HRA Pharma’s application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States.

CHPA’s President and CEO, Scott Melville, today released the following statement in response to the FDA releasing a proposed rule on "Nonprescription Drug Product with an Additional Condition for Nonprescription Use" (ACNU):

The Consumer Healthcare Products Association (CHPA) today announced the hiring of Larisa Pavlick as its new Senior Director of Quality Assurance and Technical Affairs and Kirby Miller as its new Director of Federal Government Affairs.

CHPA’s Senior Vice President of Dietary Supplements, Duffy MacKay, ND, released the following statement in response to the U.S. Preventive Services Task Force (USPSTF) updated recommendation on vitamins, minerals, and multivitamin supplements

The Consumer Healthcare Products Association (CHPA) today announced Lisa Paley as Chair-Elect of the CHPA Board of Directors. Paley will assume the position of Board Chair in March 2023, when current CHPA Board Chair Michelle Goodridge, President, U.S. Self Care, Johnson & Johnson Consumer, Inc. concludes her chairmanship.